520168A

IP属地：未知

帖子 · 23帖子 · 23
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- 520168A520168A
  ·2021-11-02
  $JAPFA LTD.(UD2.SI)$why keep falling for months....my worse sgx stock
  1,072 评论
  2
  分享
  举报
- 520168A520168A
  ·2021-08-10
  长远的看法如何?
  非常抱歉，此主贴已删除
  1,006 1
  点赞
  分享
  举报
- 520168A520168A
  ·2021-08-10
  Good
  @520168A：
  $Halozyme Therapeutics(HALO)$Earning Above Expectations again. Promising and versatile platform to solve many unmet medical needs. Continue to hold on!
  $Halozyme Therapeutics(HALO)$Earning Above Expectations again. Promising and versatile platform to solve many unmet medical needs. Continue to hold on!
  146 评论
  点赞
  分享
  举报
- 520168A520168A
  ·2021-08-10
  $Halozyme Therapeutics(HALO)$Earning Above Expectations again. Promising and versatile platform to solve many unmet medical needs. Continue to hold on!
  373 1
  2
  分享
  举报
- 520168A520168A
  ·2021-06-18
  Nice one
  非常抱歉，此主贴已删除
  131 评论
  2
  分享
  举报
- 520168A520168A
  ·2021-06-18
  Nice one
  非常抱歉，此主贴已删除
  26 评论
  点赞
  分享
  举报
- 520168A520168A
  ·2021-06-18
  Nice
  非常抱歉，此主贴已删除
  259 1
  3
  分享
  举报
- 520168A520168A
  ·2021-05-05
  $Root, Inc.(ROOT)$ 卖出，忍痛断根斩仓
  1,345 1
  2
  分享
  举报
- 520168A520168A
  ·2021-04-26
  $Axsome Therapeutics(AXSM)$The FDA has set a Prescription Drug User Fee Act (PDUFA) target action date for the AXS-05 NDA of August 22, 2021.
  476 评论
  2
  分享
  举报
- 520168A520168A
  ·2021-04-26
  Axsome Therapeutics Announces FDA Acceptance and Priority Review of New Drug Application for AXS-05 for Treatment of Major Depressive Disorder
  非常抱歉，此主贴已删除
  476 评论
  1
  分享
  举报

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们